Home > Inhibitors & Agonists > Nuclear Receptor/Transcription Factor > RAR/RXR
Cat. No. Product name CAS No.
DC7054 AM580 Featured

A retinoic acid analog and selective RARα agonist

102121-60-8
DC11149 AC261066

AC261066 (AC-261066, AC261) is a potent, selective, orally available RARβ2 agonist with pEC50 of 8.1, displays selectivity over RARβ1, RARα and RARγ (pEC50=6.4, 6.2 and 6.3).

870773-76-5
DC10135 AR-7 Featured

AR7 is a retinoic acid receptor α (RARα) antagonist.

80306-38-3
DC10491 CD437 Featured

CD437 is a synthetic retinoid that is an RARγ-selective agonist. It displays RARγ-dependent and -independent effects on differentiation and apoptosis.

125316-60-1
DC7714 Fenretinide (4-HPR) Featured

Fenretinide (4-HPR) is a synthetic retinoid deriverative. 4-HBR is shown to exhibit binding to the retinoic acid receptors (RAR) at concentrations necessary to induce cell death.

65646-68-6
DC11167 HX600

HX600 (HX-600) is a synthetic agonist of RXR-Nurr1 heterodimer complex, also selectively activate NGFI-B/RXR heterodimers.

172705-89-4
DC10833 LY2955303 Featured

LY2955303 is a potent and selective RAR-gamma antagonist for the treatment of osteoarthritis pain.

1433497-19-8
DC11245 UAB30

UAB30 (9cUAB30) is a novel synthetic rexinoid that binds selectively to the retinoid X receptor (RXR) leading to activation of genes involved in induction of differentiation and apoptosis.

205252-59-1
DC28196 Ch55

Ch55 is a potent synthetic retinoid. Ch55 binds to RAR-α and RAR-β receptors with high affinity. Ch55 displays low affinity for cellular retinoic acid binding protein (CRABP). Ch55 is a potent inducer of the differentiation of HL60 cells with an EC50 of 200 nM. Ch55 can be used for cancer research.

110368-33-7
DC28197 CD3254

CD3254 a potent and selective retinoid-X-receptor (RXR) agonist.

196961-43-0
DC28199 CD2665

CD2665 is a selective RAR-beta/gamma antagonist, with Ki values of 110 nM, 306 nM for RARγ and RARβ, respectively.

170355-78-9
DC28236 PA452

PA452, retinoic X receptor (RXR) specific antagonist, inhibits the effect of Retinoic acid (RA) on Th1/Th2 development.

457657-34-0
DC28237 LG100754

LG100754 (UVI 2112) is a RXR dimers modulater. LG100754 acts as a RXR:RXR homodimer antagonist, but functions as a agonist towards RXR:PPARα and RXR:PPARγ heterodimers. LG100754 is an insulin sensitizer that functions through RXR.

180713-37-5
DC28238 Fluorobexarotene

Fluorobexarotene (compound 20) is a potent retinoid-X-receptor (RXR) agonist, with a Ki value of 12 nM and an EC50 value of 43 nM for RXRα receptor. Fluorobexarotene possesses an apparent RXR binding affinity that is 75% greater than Bexarotene.

1190848-23-7
DC28957 AGN194204

AGN194204 (IRX4204) is an orally active and selective RXR agonist with Kd values 0.4 nM, 3.6 nM and 3.8 nM and EC50s of 0.2 nM, 0.8 nM and 0.08 nM for RXRα, RXRβ and RXRγ, respectively. AGN194204 is inactive against RAR. AGN194204 has anti-inflammatory and anticarcinogenic actions.

220619-73-8
Page 1 / Total 1 FirstPrevNextLastGoto